Application
LMA1L Antibody (Center) western blot analysis in HL-60 cell line lysates (15ug/lane).This demonstrates the LMA1L antibody detected the LMA1L protein (arrow).Application
LMA1L Antibody (Center) flow cytometric analysis of HL-60 cells (right histogram) compared to a negative control cell (left histogram).FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.| Product Name | LMA1L Antibody (Center) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | LMAN1L; ERGL; Protein ERGIC-53-like; ERGIC53-like protein; Lectin mannose-binding 1-like |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WBFC |
| WB:1:100~500 FC |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | ERGL |
|---|---|
| Alternative Names | LMAN1L ERGL Protein ERGIC-53-like ERGIC53-like protein Lectin mannose-binding 1-like |
| Molecular Weight(MW) | 57129 Da |
| Tissue Specificity | Highly expressed in normal and neoplastic prostate. Also expressed in cardiac atrium, salivary gland, spleen and selective cells in the CNS |
| Cellular Localization | Endoplasmic reticulum-Golgi intermediate compartment membrane; Single-pass type I membrane protein (By similarity) |
| Entrez Gene | 79748 |
|---|---|
| Nucleotide Accession | NP_068591.2 |
Application
LMA1L Antibody (Center) western blot analysis in HL-60 cell line lysates (15ug/lane).This demonstrates the LMA1L antibody detected the LMA1L protein (arrow).
Application
LMA1L Antibody (Center) flow cytometric analysis of HL-60 cells (right histogram) compared to a negative control cell (left histogram).FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.| Application Notes | WB:1:100~500 FC |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
